Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3 Clinical Trials in Barcelona

A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3